Uflex says COVID-19 may propel development of sterile, anti-microbial packaging solutions

Himadri Buch Uflex revenues could grow 12-15% in FY21, as new projects are commissioned during the year, Rajesh Bhatia, Group President (Finance Accounts) CFO UFlex told Moneycontrol

No comments:

Post a Comment